New Zealand markets open in 9 hours 22 minutes

Charles River Laboratories International, Inc. (CRL)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
241.34-5.08 (-2.06%)
At close: 04:00PM EDT
241.41 +0.07 (+0.03%)
Pre-market: 08:10AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 12.43B
Enterprise value 15.22B
Trailing P/E 26.18
Forward P/E 22.03
PEG ratio (5-yr expected) 1.87
Price/sales (ttm)3.01
Price/book (mrq)3.46
Enterprise value/revenue 3.69
Enterprise value/EBITDA 14.75

Trading information

Stock price history

Beta (5Y monthly) 1.41
52-week change 315.72%
S&P500 52-week change 323.42%
52-week high 3275.00
52-week low 3161.65
50-day moving average 3251.06
200-day moving average 3215.28

Share statistics

Avg vol (3-month) 3539.23k
Avg vol (10-day) 3468.3k
Shares outstanding 551.51M
Implied shares outstanding 651.51M
Float 850.74M
% held by insiders 10.98%
% held by institutions 1103.03%
Shares short (28 Mar 2024) 41.58M
Short ratio (28 Mar 2024) 43.18
Short % of float (28 Mar 2024) 43.99%
Short % of shares outstanding (28 Mar 2024) 43.08%
Shares short (prior month 29 Feb 2024) 41.75M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2023
Most-recent quarter (mrq)30 Dec 2023

Profitability

Profit margin 11.49%
Operating margin (ttm)14.52%

Management effectiveness

Return on assets (ttm)5.19%
Return on equity (ttm)14.38%

Income statement

Revenue (ttm)4.13B
Revenue per share (ttm)80.61
Quarterly revenue growth (yoy)-7.90%
Gross profit (ttm)N/A
EBITDA 970.29M
Net income avi to common (ttm)474.62M
Diluted EPS (ttm)9.22
Quarterly earnings growth (yoy)-0.20%

Balance sheet

Total cash (mrq)276.77M
Total cash per share (mrq)5.39
Total debt (mrq)3.13B
Total debt/equity (mrq)85.46%
Current ratio (mrq)1.52
Book value per share (mrq)70.06

Cash flow statement

Operating cash flow (ttm)683.9M
Levered free cash flow (ttm)218.76M